CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,360 | -37.9% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,190 | -31.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $3,190 | -23.9% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $4,190 | -48.4% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $8,120 | +7.5% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $7,550 | -13.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $8,680 | -22.2% | 1,000 | -28.6% | 0.00% | -100.0% |
Q4 2020 | $11,158 | -0.1% | 1,400 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $11,165 | -19.4% | 1,400 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $13,860 | +28.1% | 1,400 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $10,822 | +100.8% | 1,400 | 0.0% | 0.00% | – |
Q4 2019 | $5,390 | -23.5% | 1,400 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $7,042 | -23.9% | 1,400 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $9,254 | -12.7% | 1,400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,598 | -6.3% | 1,400 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $11,312 | -37.4% | 1,400 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $18,060 | +13.2% | 1,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $15,960 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
Avenir Corp | 150,600 | $580,000 | 0.06% |
HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |